SCHEMBL730626

SCHEMBL730626

CC(C)C(O)C(C)(C)C=O

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isobutyraldehyde SCHEMBL6472427 0.93
SCHEMBL195747 0.77
SCHEMBL483574 0.73
SCHEMBL19766427 0.72 TRPA1 (0.30) TRPA1
SCHEMBL13849138 0.71
SCHEMBL6472432 0.69 PGD (0.33)
SCHEMBL270229 0.69
SCHEMBL888909 0.68
SCHEMBL2744382 0.68
SCHEMBL888915 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1856 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146122-A1 POLYMERS MOLECULAR MEDICAL LTD (GB) 2026-05-28 US claimed
US-20260132095-A1 METHOD FOR PREPARING NEOPENTYL GLYCOL LG CHEM LTD (KR) 2026-05-14 US claimed
EP-4474360-B1 METHODS AND COMPOSITIONS FOR INHIBITING CORROSION ON METAL SURFACES CHEMTREAT INC (US) 2026-04-29 EP claimed
EP-4732355-A1 BATTERY ELECTRODE AND METHOD OF MAKING THE SAME Syensqo Specialty Polymers Italy S.p.A. (IT) 2026-04-29 EP claimed
EP-4732356-A1 BATTERY ELECTRODE AND METHOD OF MAKING THE SAME Syensqo Specialty Polymers Italy S.p.A. (IT) 2026-04-29 EP claimed
US-12600878-B2 Topcoat layer, a lamination film containing the same, and a decorative article decorated by said lamination film BASF COATINGS GMBH (DE) 2026-04-14 US claimed
EP-4720665-A1 METHOD OF DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE Molecular You Corporation (CA) 2026-04-08 EP claimed
EP-3423506-B1 STYRENE-FREE REACTIVE DILUENTS FOR URETHANE ACRYLATE RESIN COMPOSITIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2026-03-25 EP claimed
US-20260081178-A1 POSITIVE ELECTRODE PLATE AND ELECTROCHEMICAL DEVICE CONTEMPORARY AMPEREX TECHNOLOGY HONG KONG LTD (CN) 2026-03-19 US claimed
US-12570783-B2 Styrene acrylate-siloxane composite emulsion with core-shell structure, and preparation method and use thereof Qingdao university of technology (CN) 2026-03-10 US claimed
CN-110790666-A Preparation method of ethyl 2,2, 4-trimethyl-3-hydroxypentanoate, water-based paint for containers and preparation method of water-based paint 润泰化学(泰兴)有限公司 2020-02-14 CN claimed
CN-110746297-A Preparation method of 2,2, 4-trimethyl-3-hydroxy methyl valerate, water-based industrial paint for steel structure and preparation method of water-based industrial paint 润泰化学(泰兴)有限公司 2020-02-04 CN claimed
CN-110746298-A Preparation method of isobutyl 2,2, 4-trimethyl-3-hydroxypentanoate, really stone paint and preparation method thereof 润泰化学(泰兴)有限公司 2020-02-04 CN claimed
CN-110724055-A Preparation method of n-butyl 2,2, 4-trimethyl-3-hydroxypentanoate, latex paint and preparation method thereof 润泰化学(泰兴)有限公司 2020-01-24 CN claimed
CN-107698451-A A kind of production technology of alcohol ester 12 安徽省化工设计院 2018-02-16 CN claimed
US-20120142081-A1 BIOSYNTHESIS OF COMMODITY CHEMICALS BIO ARCHITECTURE LAB, INC. (US) 2012-06-07 US claimed
EP-2361310-A2 BIOSYNTHESIS OF COMMODITY CHEMICALS Bio Architecture Lab, Inc. (US) 2011-08-31 EP claimed
US-8003365-B2 converting sugars and polysaccharides, as well as various aldehydes and/or ketones, into commodity chemicals, such as biofuels isooctane, 2-ethylhexane, and 2-butyloctane; recombinant microorganisms; biofuel blends with petroleum fuels BIO ARCHITECTURE LAB, INC. (US) 2011-08-23 US claimed
US-20100185017-A1 BIOSYNTHESIS OF COMMODITY CHEMICALS BIO ARCHITECTURE LAB, INC. 2010-07-22 US claimed
WO-2010068921-A2 BIOSYNTHESIS OF COMMODITY CHEMICALS BIO ARCHITECTURE LAB, INC. (US) 2010-06-17 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100185017-A1 BIOSYNTHESIS OF COMMODITY CHEMICALS COASY, HSD17B14, FASN TRPA1 3319/4885
US-12570783-B2 Styrene acrylate-siloxane composite emulsion with core-shell structure, and preparation method and use thereof MSMO1, STS, ATM TRPA1 3356/4885
US-20260132095-A1 METHOD FOR PREPARING NEOPENTYL GLYCOL ADH5, HPD, ADH1C TRPA1 4455/4885
US-20260146122-A1 POLYMERS FGB, IPMK, PFKP TRPA1 3618/4885
US-20260081178-A1 POSITIVE ELECTRODE PLATE AND ELECTROCHEMICAL DEVICE TPO, VDAC1, AOC2 TRPA1 185/4885
US-12600878-B2 Topcoat layer, a lamination film containing the same, and a decorative article decorated by said lamination film HHAT, HTR3D, EIF4A3 TRPA1 4010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.